The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California.
| Revenue (TTM) | $4.24B |
| Gross Profit (TTM) | $2.79B |
| EBITDA | $932.00M |
| Operating Margin | 20.80% |
| Return on Equity | 6.84% |
| Return on Assets | 2.74% |
| Revenue/Share (TTM) | $21.69 |
| Book Value | $43.81 |
| Price-to-Book | 1.45 |
| Price-to-Sales (TTM) | 2.80 |
| EV/Revenue | 3.413 |
| EV/EBITDA | 15.46 |
| Quarterly Earnings Growth (YoY) | 357.10% |
| Quarterly Revenue Growth (YoY) | 0.60% |
| Shares Outstanding | $190.16M |
| Float | $188.77M |
| % Insiders | 0.63% |
| % Institutions | 111.50% |
Volatility is currently expanding
SAN RAMON, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report fourth quarter and full year 2026 financial results on Thursday, December 3, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
SAN FRANCISCO, Oct. 30, 2026 /PRNewswire/ -- On September 10, 2026, investors in The Cooper Companies, Inc. (NASDAQ: COO) saw the price of their shares trade down $9.31 (-14.6%) after the company reported Q3 2026 financial results that included revelations of its U.S. channel inventory destocking along with other negative surprises. The stock's move lower wiped out over $1.7 billion of the company's market capitalization.
Investigation follows the September 9, 2026 disclosure regarding The Cooper Companies, Inc.; investors who lost money may have claims to recover their losses Investigation follows the September 9, 2026 disclosure regarding The Cooper Companies, Inc.; investors who lost money may have claims to recover their losses
NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Cooper Companies, Inc. (NASDAQ: COO) resulting from allegations that Cooper Companies may have issued materially misleading business information to the investing public.
Independent Director and Seasoned Healthcare Executive Walt Rosebrough Elected Executive Chair; Search for CEO Underway
NEW YORK, Oct. 25, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Cooper Companies, Inc. (NASDAQ: COO) resulting from allegations that Cooper Companies may have issued materially misleading business information to the investing public.
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Cooper Companies, Inc. ("Cooper" or the "Company") (NASDAQ: COO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Cooper Companies, Inc. (“Cooper” or the “Company”) (NASDAQ: COO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
New York, New York--(Newsfile Corp. - October 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Cooper Companies, Inc. (NASDAQ: COO) resulting from allegations that CooperCompanies may have issued materially misleading business information to the investing public. SO WHAT: If you purchased CooperCompanies securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Cooper Companies, Inc. (NASDAQ: COO) resulting from allegations that Cooper Companies may have issued materially misleading business information to the investing public.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on COO and any ticker you trade — then tracks every position and per-strategy win rate.
